NEOGENOMICS INCNEOEarnings & Financial Report
Nasdaq · Industrials · Services-Testing Laboratories
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 15.70% | 20.0M | — | 2024-01-22 |
| The Vanguard Group | 11.12% | 14.2M | — | 2024-02-13 |
| S.S. OR | 5.20% | 6.6M | — | 2024-11-14 |
| T. Rowe Price Investment Management, Inc. | 5.10% | 6.5M | ▲ +0.10pp | 2024-11-14 |
| Brown Advisory Incorporated | — | 9.5M | — | 2024-02-09 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-01 | Zook Anthony P. | Chief Executive Officer | Option exercise | 140.5K | $0.00 | $0 |
| 2026-04-01 | Warren Stone | Pres & Chief Operating Officer | Option exercise | 17.6K | $0.00 | $0 |
| 2026-02-23 | Sherman Jeffrey Scott | Chief Financial Officer | Option exercise | 15.5K | $0.00 | $0 |
| 2026-02-23 | Warren Stone | Pres & Chief Operating Officer | Option exercise | 8.4K | $0.00 | $0 |
| 2026-02-23 | Olivo Alicia C | EVP, GC & Business Development | Option exercise | 8.4K | $0.00 | $0 |
| 2026-02-21 | Sherman Jeffrey Scott | Chief Financial Officer | Option exercise | 42.2K | $0.00 | $0 |
| 2026-02-21 | Warren Stone | Pres & Chief Operating Officer | Option exercise | 28.1K | $0.00 | $0 |
| 2026-02-21 | Aunan Greg D | Chief Accounting Officer | Option exercise | 6.3K | $0.00 | $0 |
| 2026-02-21 | Olivo Alicia C | EVP, GC & Business Development | Option exercise | 21.1K | $0.00 | $0 |
1–9 of 9